...Fabio Levi; Carlo La Vecchia; Franca Lucchini; Van Cong Te; Silvia Franceschi Trends in mortality from Hodgkin’s disease (HD) and non-Hodgkin’s lymphomas (NHL) in the whole of Europe and in two broad European geographic areas (Western and Eastern Europe) were reviewed over the period of 1960-1990...

...Lüder M. Fels; Carsten Bokemeyer; Jutta van Rhee; Hans-Joachim Schmoll; Hilmar Stolte Chemotherapy (Ctx) and/or radiotherapy (Rtx) are effective in the treatment of Hodgkin’s disease (HD) but potentially involve late toxicities, including nephrotoxic side effects. Therefore a follow-up study has...

...Àrpàd Illés; Anikó Bànyai; Györgyi Vadàsz; Gyula Szegedi We report four cases of Hodgkin’s disease (HD) relapsing after complete remission for over a 10-year period after the initial therapy. Three of the patients had mixed-cellularity subtypes as a primary histological diagnosis...

...Roger M. Macklis; Peter M. Mauch; Lynn Thompson; Steven J. Burakoff; Brian R. Smith We have evaluated the immunophenotype and function of presumptive NK cells taken from Hodgkin’s disease patients before and after mantle/para-aortic lymphoid irradiation. We find that the lymphoid irradiation...

...J. Szántó; T. Fleischmann; S. Eckhardt Starting in January 1984, 63 patients with resistant Hodgkin’s disease received CEP as salvage –usually third-line – chemotherapy. Complete response (CR) was achieved in 3%, partial response (PR) in 51%. The median duration of remission (CR + PR) was greater...

... rearranged TCRγ and JH genes. In Hodgkin’s disease in 3 out of 7 cases rearranged immunoglobulin genes were detected. In 1 case, which was diagnosed as a follicular hyperplasia, rearranged JH and TCRγ fragments appeared. In none of the analyzed lymphomas could bcr rearrangements be observed. 26 6 2009...

...K. Merk; M. Björkholm; E. Rengifo; J. Gavilondo; G. Holm; H. Rivas In this register study the epidemiologic features of Hodgkin’s disease (HD) in Cuba and Sweden during 1964–1981 are compared. HD in the adult (≥15 years of age) is more common in Sweden than in Cuba (age-standardized incidence rate...

...W.R. Bezwoda; R. Dansey; M.A. Bezwoda An analysis of the therapy details of 99 patients receiving primary MOPP chemotherapy for Hodgkin’s disease revealed that treatment modification was a frequent occurrence. The mean cumulative dose calculated as a percentage of the projected ideal dose was 76...

...Moshe Sonnenblick; Mordechai R. Kramer; Chaim Hershko A 72-year-old female is described in whom immune thrombocytopenia (ITP) and fever were the presenting features of stage IIB Hodgkin’s disease (HD) of the nodular sclerosis type. Thrombocytopenia resolved following steroid therapy, and after...

...Beena N. Gulwani; S.H. Advani; Sudha G. Gangal Our earlier studies have demonstrated that the peripheral blood mononuclear cells (PBMNC) of patients with Hodgkin’s disease (HD) have reduced percentage of Tμ cells and increased percentage of Tγ cells, while the splenic MNC showed the reversed...

...S. Eridani; A.K. Singh A patient seen at presentation for Hodgkin’s disease (HD) at stage IV B was successfully treated with MOPP. In remission he developed coeliac disease, controlled by dietary measures, but 26 months after the end of chemotherapy a severe dyspeptic syndrome appeared; endoscopy...

...Bogna Wierusz-Wysocka; Henryk Wysocki The activity inducing PMN aggregation, the chemotactic activity, and the activity augmenting PMN adherence were estimated in plasma of 40 untreated patients with Hodgkin’s disease. The first two activities were evident in all patients with advanced clinical...

...D. Douer; C. Chaimoff; A.I. Pick; J. Pinkhas Mean serum immunoglobulin levels (IgG, IgA, IgM) in splenectomized Hodgkin’s disease patients in remission were compared with a control group of splenectomized healthy subjects following trauma. The controls showed a higher IgA and lower IgM than...

...William Rosenberg; Martin M. Oken; Robert E. Rydell; Manuel E. Kaplan A patient is described who developed a diffuse histiocytic lymphoma (DHL) 9 years after radiation therapy for Hodgkin’s disease. This occurrence is of particular interest because the treatment for Hodgkin’s disease included...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Dinitrochlorobenzene Hodgkin’s disease Immunopotentiation Sensitization Oncology 36: 23-26 (1979) Possible Nonspecific Immunopotentiation by 2,4-DinitrochIorobenzene Sensitization in Patients...

...James D. Cox; Thomas J. Stoffel During an 11-year period, 76 patients with pathologic stage (PS) and 69 with clinical stage (CS) I and II Hodgkin’s disease were irradiated. The PS and CS patients were comparable by sex, age, stage, and histopathologic types. Treatment group 1 received a mantle...

...K. Brace; A.A. Serpick; J.B. Block; P.H. Wiernik 22 patients with previously untreated stage I and II Hodgkin’s disease, representing all of the Lukes und Bulter histologic types, were randomized to three treatment programs. Patients in group A received radiotherapy to involved plus adjacent node...

...E. Perlin; P.H. Levine; J. McCoy; J. Dean; R. Herberman Hodgkin’s disease may sporadically occur in more than one member of a family. A family in which two siblings were documented to have the nodular sclerosing form of the disease was studied for immological competency, distribution of HL...

...E. Viadana; I.D.J. Bross; J.W. Pickren An autopsy study was performed on 190 cases with Hodgkin’s disease and on 134 cases with reticulum cell sarcomas. It was found that a cascade spread of metastases, as opposed to a random spread, was detectable in patients with Hodgkin’s disease...

...P. Khilanani; M. Al-Sarraf The case described is that of a patient who initially presented with bleeding tendency characterized by epistaxis, bruises, and purpura for 6 years which was subsequently diagnosed as autoimmune thrombocytopenia. The patient was found to have Hodgkin’s disease, stage III...